Biopsy cited in call for delaying prison
The ex-Qwest exec's doctor says he'll know Friday if the leg
growth needs treatment.
By Andy Vuong
Wednesday, March 18, 2009
Joe Nacchio's dermatologist conducted a biopsy Monday on a
"suspicious growth" on the former Qwest chief executive's leg to
test it for skin cancer, according to a court filing Tuesday.
The results of the test will be known by Friday morning, Dr.
Warren Zwecker wrote in a letter filed in Denver federal court
connected to Nacchio's motion to delay the date he must report
to prison for his insider trading conviction.
U.S. District Judge Marcia Krieger has ordered Nacchio to report
to a Pennsylvania prison camp
by noon on Monday to begin serving a six-year term.
Nacchio's attorneys have asked to delay the date until April 7
so he can receive the required treatment. A hearing is
scheduled for Thursday.
The government argued in a filing Tuesday that the motion should
be denied because Nacchio can receive medical care in prison.
"Regardless of whether Mr. Nacchio's biopsy is benign or
malignant, the Federal Bureau of Prisons is equipped to handle
his condition," assistant U.S. attorney
Kevin Traskos states.
Nacchio, 59, has been treated for several months for the
suspicious growth, according to court documents unsealed
Tuesday. Zwecker said the mass responded slightly to
treatment administered during a February visit, but he remained
"concerned" and decided to perform the biopsy.
If the mass is benign, the "appropriate medical protocol" would
be for him to examine Nacchio again on March 26, Zwecker said.
If it is malignant, surgery would be required as soon as
possible, with a follow-up visit 10 days to two weeks later.
Nacchio's attorney Maureen Mahoney did not respond to requests
for comment Tuesday.
Nacchio was convicted on 19 counts of insider trading, accused
of selling millions in Qwest stock in early 2001 after receiving
warnings from top executives that the company was struggling
Andy Vuong: 303-954-1209 or